The purpose of the study is to examine the differences in insulin resistance and postprandial triglyceride (TG) response between hypertensive patients with or without hypertriglyceridaemia. The study is a comparative cohort study with matching. Thirty-one newly diagnosed hypertensive patients without any medication were recruited from a health survey. The participants were further divided into two groups: those with fasting TG Ͻ2.26 mmol/L, and those with TG between 2.26 and 5.65 mmol/L. Both groups were matched in age, sex, body mass index and waist circumference. Each patient received a 75-g oral glucose tolerance test, an insulin suppression test, and a 1000 kcal high fat mixed meal test. The hypertriglyceridaemic hypertensive patients had significantly higher fasting insulin, 2-h plasma glucose, 2-h insulin, and steady-state plasma glucose (SSPG) (13.16 ± 1.87 vs 9.76 ± 3.18 mmol/L). They also had a greater postprandial TG response to the challenge
Introduction
Hypertension often clusters with type 2 diabetes mellitus (DM), obesity and dyslipidaemia in what is called the insulin resistance syndrome. 1 Hypertension and the clustering metabolic derangement increase the risk of cardiovascular disease (CVD). 2 Insulin resistance has been proposed to be the key metabolic abnormality linked to hypertension. 3 However, not all hypertensive patients have insulin resistance. It was estimated that 25% of unmedicated hypertensive patients were insulin resistant.
Grundy has suggested using hypertriglyceridaemia as a lead to identify the patients susceptible to insulin resistance. 5 Bonora et al 6 showed that the prevalence of insulin resistance increased two-fold to around 60% in hypertensive subjects combined with other components of the insulin resistance syndrome. About 30% of hypertensive patients were reported to have fasting triglyceride (TG) levels higher than 2.26 mmol/L. 7 The chance to identify insulin resistance in hypertensive subjects with hypertriglyceridaemia should be higher than that in those without it.
Hypertension imparts a two-to three-fold increased risk of CVD. Insulin resistance and compensatory hyperinsulinaemia have been reported to predict CVD independently. 8 Hypertriglyceridaemia is a conspicuous marker for increased risk of CVD in hypertensive patients. 9 Dyslipidaemia in hypertensive patients rarely occurs as an isolated problem. As reported by Stern et al, 7 80-90% of hypertensive patients with hypertriglyceridaemia were combined with high levels of low-density lipoprotein cholesterol and/or low levels of high-density lipoprotein cholesterol (HDL-C). In addition, increased postprandial TG response may also play an important role in the pathogenesis of CVD. 10 Exaggerated postprandial TG levels have been reported in persons with fasting hypertriglyceridaemia, 11 visceral obesity, 12 and type 2 DM. 13 However, there was little study on postprandial TG response in patients with hypertension.
14 Multiple risk factors tend to increase CVD risk synergistically. Therefore, it is warranted to study postprandial TG response in hypertensive patients.
In the present study, we hypothesised that there would be a significant difference in insulin resistance and postprandial TG response between hypertensive patients with or without hypertriglyceridaemia.
Subjects and methods

Subjects
Thirty-one newly diagnosed hypertensive patients (20 men and 11 women) without any medication were recruited from a health survey at the Clinics of General Medicine. The diagnosis of hypertension was made when the average of two or more diastolic blood pressure (DBP) measurements on at least two visits was higher than 90 mm Hg or when the average of multiple systolic BP (SBP) readings on two or more visits was consistently higher than 140 mm Hg. 2 Their age ranged from 20 to 72 years and body mass index (BMI) was less than 35 kg/m 2 . They did not have liver, kidney, blood, heart or neurological diseases nor known secondary causes of hypertension such as renovascular disease, renal failure, pheochromocytoma, aldosteronism or genetic diseases. Subjects with frank DM, thyroid problems or Cushing's syndrome were excluded from the study. No one had acute illness in the previous 6 months. Women who were pregnant or breast-feeding were not included. No concomitant medication, including hormone replacement, was allowed in the study. The participants with the habit of drinking alcohol were excluded from the study. We divided the participants into two groups according to the fasting serum TG levels. The hypertensive patients with fasting TG Ͻ2.26 mmol/L were designated as the hypertensive (HT) group and those with TG between 2.26 and 5.65 mmol/L as the HT + TG group. Patients with fasting TG higher than 5.65 mmol/L were excluded from the study. Subjects with fasting serum total cholesterol (TC) higher than 6.48 mmol/L were also excluded. were matched between both groups. Written informed consent was obtained from each subject after the explanation of the purpose, nature and possible adverse effects of the study.
Anthropometric, body composition and BP examination
The subjects received anthropometric and body composition measurements 15 at 8 am after a 12-h overnight fast. Body weight (BW) was measured to the nearest 0.1 kg and body height (BH) to the nearest millimeter. BMI was calculated as BW (kg) divided by BH squared (m 2 ). Hip circumference (H) was measured at the level of the maximal protrusion of the gluteal muscles over the underwear and recorded to the nearest millimeter. Waist circumference (W) was measured at the level of umbilicus to the nearest millimeter. Waist-to-hip ratio (W/H) was calculated by W divided by H. Whole body bioelectric impedance analysis was performed by a portable impedance analyzer (BIA 101, RJL Systems, Detroit, MI, USA) with subjects in supine position. 15 The resistance (in ohm) and reactance (in ohm) detected by the impedance analyzer were recorded. Total body fat mass and body fat percentage (fat %) were calculated by Segal's regression equation. 16 Supine BP was taken on right arm by a sphygmomanometer (Baumanometer, W. A. Baum Co Inc, Copiague, NY, USA) twice after 10 min of rest. The cuff size was determined by the arm circumference. An initial pressure of 30 mm Hg above the pulse obliteration pressure was applied. SBP and DBP were recorded to the nearest 2 mm Hg by phase I and V of the Korotkoff sounds. The means of BP measurements were reported. The same technician carried out all the above procedures.
Metabolic assessments
Each patient received a 75-g oral glucose tolerance test (OGTT), an insulin suppression test (IST), and a 1000 kcal high fat mixed meal test (MMT) at intervals of at least 3 days. Subjects refrained from strenuous exercise 3 days before the tests. No alcohol was allowed in the 3 days preceding each test. The OGTT was done by procedures reported previously. 17 A 75-g glucose monohydrate (in 300 ml water) was administered to the subject in the morning after the baseline fasting samples were taken. Blood samples were taken 30, 60, 90 and 120 min after glucose loading for the measurements of plasma glucose (PG) and insulin. The IST was performed at 8 am after a 12-h overnight fast. 18 All subjects were infused with regular insulin (Humulin-R, Lilly, IN, USA; 25 mU/min m (Stilamin, Serono, Aubonne, Switzerland) was infused intravenously over the same period of time. Arterialised venous blood samples were collected at −10, 0, 30, 60, 90, 120, 150, 160, 170 and 180 min during the IST for PG and insulin. The mean value of PG at 150, 160, 170 and 180 min is defined as steady-state plasma glucose (SSPG), and so is the insulin, as steady-state plasma insulin (SSPI). The MMT was carried out by a protocol reported before. 13, 19 In brief, the patients received the MMT in the morning after an overnight fast of 12 h. After the collection of the baseline blood samples, the patients were subjected to a 1000 kcal mixed meal consisting of 73 g (65.9% of calories) fat, 47 g (18.9%) carbohydrates and 38 g (15.2%) protein. The meal included scrambled eggs, bread, hot dog and whole milk added with sugar. Then the subjects fasted for another 8 h. Blood samples were taken hourly after the meal for the measurements of PG, insulin and TG.
Measurements
PG was measured by a glucose oxidase method (glucose analyzer model 2300, YSI, Yellow Springs, OH, USA). The plasma insulin was measured by an in-house radioimmunoassay. The sensitivity of the assay was 17 pmol/L. The cross-reactivity with Cpeptide, glucagon and proinsulin were 0.025%, 0.14% and 17.5%, respectively. Serum TC and TG levels were measured by enzymatic methods using assay kits (Boehringer Mannheim, GmbH, Mannheim, Germany) in an automatic blood chemistry analyzer (Model 736, Hitachi, Tokyo, Japan). Serum HDL-C was determined by an enzymatic cholesterol assay after dextran sulfate precipitation. The glycated haemoglobin (HbA 1c ) was measured by high-pressure liquid chromatography (Bio-Rad Laboratories, Anaheim, CA, USA). The reference range of HbA 1c is 4 -6%.
Statistical analysis
All values were expressed as mean ± s.d. and/or median (range). Two-sample t-tests were applied to the continuous data and 2 tests of categorical data to compare the differences between the two groups. The non-parametric Mann-Whitney U tests were also applied to fat %, TG, HDL-C, and fasting insulin for comparison. Tai's mathematical model was used for the determination of the area under curve of the MMT. 20 Pearson and partial correlation procedures were used to test the correlation of SSPG and fasting TG with the TG response of MMT in all patients initially. Then, Spearman's rank correlation analysis was performed again on the unadjusted data. The level of significance chosen is P Ͻ 0.05. Table 1 shows the baseline clinical characteristics of the patients. Both groups were compatible in age, sex, BW, BMI, W, W/H, fat mass and BP. By recruitJournal of Human Hypertension ment criteria, the HT + TG group had higher fasting TG levels than the HT group. There were no differences between both groups in TC and HDL-C. Although fasting PG and HbA 1c levels were alike in both groups, fasting insulin concentrations were higher in the HT + TG group. The results of OGTT are demonstrated in Figure 1 . The hypertensive patients with hypertriglyceridaemia had higher 2-h PG (10.43 ± 2.50 vs 8.38 ± 2.11 mmol/L) and insulin (708 ± 250 vs 500 ± 215 pmol/L) values. The HT + TG group also had a higher rate of impaired glucose tolerance (11 out of 16 participants) than the HT group (six out of 15). But the numbers of undiagnosed DM were proportional between both groups (three in the HT + TG and two in the HT group). Figure 2 shows the results of insulin suppression test. The SSPI levels (365 ± 69 vs 324 ± 86 pmol/L) were equivalent in both groups of patients ( Figure  2 , left panel), whereas the SSPG (13.16 ± 1.87 vs 9.76 ± 3.18 mmol/L) was higher in the hypertensive patients with hypertriglyceridaemia than that in the patients with fasting TG less than 2.26 mmol/L (Figure 2, right panel) . The results of MMT were reported in Figure 3 (Figure 3b ). The peak TG increase occurred at the 4th hour after mixed meal loading in hypertensive patients without hypertriglyceridaemia, while the hypertensive hypertriglyceridaemic patients had an hour delay in reaching the peak (Figure 3b) . The postprandial TG response did not return to baseline in both groups at the end of the study (Figure 3b) . The postprandial TG response (⌬TG at 4-h, 5-h and 8-h, AUC and ⌬AUC) was closely correlated (r = 0.72-0.95, P Ͻ 0.0001) with fasting TG levels in our hypertensive patients (Table 2 ). Both fasting TG and the postprandial TG response were significantly (P Ͻ 0.05) correlated with SSPG values in all patients (n = 31) before and after adjustment of age and sex ( Table 2 ). The results from the Spearman's analysis are similar to the parametric methods. The correlation coefficients of fasting TG with SSPG and ⌬AUC of TG were 0.61 and 0.85 (both P Ͻ 0.0001), respectively.
Results
Discussion
Hypertension is probably a heterogeneous collection of overlapping subtypes of pathophysiological mechanisms. Data from a Utah family study has shown that a subset of hypertension is associated with metabolic abnormalities involving lipids and 2 tests were applied to the sex distribution data, Mann-Whitney U tests to fat %, TG, HDL-C, and fasting insulin, and two-sample t-tests to other data to compare the differences between the two groups. *P Ͻ 0.05 vs the HT group.
Figure 1 Results of the 75-g oral glucose tolerance tests (OGTT).
Although fasting plasma glucose concentrations were alike in both groups, fasting insulin levels were higher in the hypertensive patients with hypertriglyceridaemia (designated as HT + TG) than in those without it (as HT). The HT + TG group also had higher 2-h plasma glucose and insulin values than the HT group. *P Ͻ 0.05 vs the HT group.
insulin. 21 Patients with 'dyslipidaemic hypertension' have a high risk of early CVD. The coronary mortality rate was approximately four-fold higher in the hypertensive patients with dyslipidaemia than in those without it. 22 A better understanding of the specific atherogenic determinants in these patients will provide targeted strategies for the detection, prevention and intervention of CVD. The purpose of the study is to examine the differences in insulin Figure 2 Results of the insulin suppression tests. The steady-state plasma insulin (SSPI) levels were equivalent in both groups of patients (left panel), whereas the steady-state plasma glucose (SSPG) concentrations were higher in the hypertensive patients with hypertriglyceridaemia (HT + TG) than in the patients with fasting TG less than 2.26 mmol/L (HT) (right panel). *P Ͻ 0.05 vs the HT group. resistance and postprandial TG response, both associated with CVD, between hypertensive patients with or without hypertriglyceridaemia. We carefully selected the newly diagnosed un-medicated participants to avoid the confounding effects of antihypertensive agents on insulin sensitivity and lipid metabolism. 23 We also matched BMI and W between the groups to skip the obesity effects on postprandial lipemia and insulin resistance.
12, 24 The results showed that the hypertensive patients with hypertriglyceridaemia were more insulin resistant than Figure 3 Results of the mixed meal tests. The patients were subjected to a 1000 kcal mixed meal consisting of 65.9% fat, 18.9% carbohydrates and 15.2% protein. The subjects fasted for another 8 h. Both groups had same plasma glucose response (a, left panel) while the patients with hypertriglyceridemia (HT + TG) had higher insulin response (a, right panel) to the meal. The serum triglyceride (TG) response (b) was also stronger in the HT + TG patients than in those without it (HT). The peak TG occurred at the 4th hour after mixed meal loading in HT group and the HT + TG group had an hour delay in reaching the peak. The postprandial TG response did not return to baseline 8 h after the meal in both groups. *P Ͻ 0.05 vs the HT group. those without it (Figures 1 and 2 ) and their postprandial TG response was exaggerated (Figure 3b ). Our data support Grundy's suggestion of using fasting TG to identify the patients susceptible to insulin resistance. 5 In the study we further demonstrate that high serum TG levels (у2.26 mmol/L) can be a marker to recognise those at risk for insulin resistance among hypertensive patients with similar body build.
Jeppesen et al 25 had provided the evidence that insulin resistance (measured by SSPG) was an independent predictor of postprandial concentrations of TG-rich lipoproteins in healthy volunteers. We demonstrated in the study that the HT + TG group were more insulin resistant than the HT group ( Figure 2) and they also had a stronger postprandial TG response to the challenge (Figure 3a) . The postprandial TG response was significantly correlated with the SSPG values in all hypertensive patients ( Table  2 ). All these data suggest a possible link between insulin resistance and postprandial lipemia. Byrne
Journal of Human Hypertension et al 26 claimed that they failed to observe the correlation between postprandial TG response and surrogate measures of insulin resistance (fasting insulin and HOMA-IR). Fasting insulin and HOMA-IR are surrogate indices derived from the fasting state. They may not be good proxy measures for the correlation between insulin resistance and postprandial parameters. We used the insulin suppression test to directly measure in vivo insulin resistance, which showed positive correlation between postprandial TG response and SSPG, as reported by Jeppesen et al. 25 In this regard, direct measurement of insulin resistance is obviously mandatory in the studies to examine the relationship between insulin resistance and the postprandial lipidaemia. In addition, the participants in the study of Byrne were not insulin resistant and their insulin sensitivity was in a narrow range. This may be another explanation for the lack of association between HOMA-IR and postprandial TG response in the study.
Fasting TG has been repeatedly reported in literature 11, 12, 13, 27 as well as in this study (Table 2) to be highly correlated with postprandial TG response. Karamanos et al 28 have challenged the relation in a recent study involved normotriglyceridaemic healthy participants with a 4-h meal test. No correlation was found between fasting TG and postprandial TG response during the 4-h meal test. Nevertheless, the meal test used in the Karamans' study is quite different from others. The total calories (470 kcal) and total amount of fat (40 g) of the test meal were much lower than other studies. The duration of the test was only 4 h instead of 8 h or longer. The peak TG concentrations and the ⌬AUC of TG response in their study could therefore be lower than those in previous studies and might not reflect the correlation between fasting TG and postprandial TG response. It is possible to take the fat load (73 g) of the current test meal in daily eating. The TG response did not return to the baseline 8 h after the meal challenge, as shown in Figure 3b . The peak TG concentrations occurred at the 5th hour instead of the 4th hour after the fat load in the hypertensive patients with hypertriglyceridaemia. Earlier studies have also shown a similar picture of time delay for peak TG in hypertriglyceridaemic CVD 11 or type 2 DM 13 patients. Hence, the maximal TG increment does not always occur at the 4th hour after a fat meal challenge. Parameters derived from TG levels at the 4th hour of a meal test, as suggested by Karamanos et al, 28 may not reflect the whole picture of postprandial TG response. The data shown here decline the conclusions made by Karamanos et al. 28 There was little study on postprandial TG response in patients with hypertension. In an earlier report, Singer and colleagues 14 found no major differences between the normotriglyceridaemic hypertensive patients and the normotensive controls in serum levels of postprandial TG. In the present study, we demonstrated that high fasting TG levels would exacerbate the postprandial TG response in patients with hypertension ( Figure 3b ). Brunzell et al 29 have reported that chylomicrons compete with very-low density lipoproteins (VLDL) for clearance by a common saturable TG removal mechanism. The fasting TG level can be regarded as a measure of the VLDL pool. 13 The higher the fasting TG is, the larger the VLDL pool, the more difficult for chylomicrons to compete with VLDL for the removal, and the higher response the postprandial TG.
In conclusion, the exacerbation of insulin resistance and postprandial TG response was identified in hypertensive patients with hypertriglyceridaemia. The postprandial TG response in hypertensive patients is associated with fasting TG and insulin resistance. The results provide a rationale for the alleviation of insulin resistance and hypertriglyceridaemia in these atherosclerosis-prone hypertensive patients.
